Triple

T21154209
Position Surface form Disambiguated ID Type / Status
Subject SIGA Technologies E521269 entity
Predicate hasContractWith P27052 FINISHED
Object U.S. Biomedical Advanced Research and Development Authority — NE NERFINISHED

How this triple was built (2 steps)

Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.

NER Named-entity recognition gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: U.S. Biomedical Advanced Research and Development Authority | Statement: [SIGA Technologies, hasContractWith, U.S. Biomedical Advanced Research and Development Authority]
NED1 Entity disambiguation (via context triple) gpt-5-mini-2025-08-07 
Target entity: U.S. Biomedical Advanced Research and Development Authority
Context triple: [SIGA Technologies, hasContractWith, U.S. Biomedical Advanced Research and Development Authority]
  • A. Biomedical Advanced Research and Development Authority chosen
    The Biomedical Advanced Research and Development Authority (BARDA) is a U.S. government agency that funds and coordinates the advanced development and procurement of medical countermeasures against public health emergencies, including pandemics, bioterrorism, and emerging infectious diseases.
  • B. Center for Biologics Evaluation and Research
    The Center for Biologics Evaluation and Research is the U.S. regulatory body responsible for overseeing the safety, efficacy, and quality of biological products such as vaccines, blood products, and gene therapies.
  • C. U.S. Army Medical Research Institute of Infectious Diseases
    The U.S. Army Medical Research Institute of Infectious Diseases is the U.S. Army’s premier biodefense laboratory, conducting high-containment research on dangerous pathogens to develop medical countermeasures against biological threats.
  • D. U.S. Army Medical Research Acquisition Activity
    The U.S. Army Medical Research Acquisition Activity is a military contracting and procurement organization that manages medical research and development acquisitions for the U.S. Army.
  • E. National Institutes of Health
    The National Institutes of Health is the United States’ primary federal biomedical research agency, supporting and conducting medical research to improve public health.
  • F. None of above.
  • G. Unsure - the case is ambiguous/there is not enough information to decide.

Provenance (2 batches)

The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.

Step Stage Batch ID Status When
creating Elicitation batch_69e0b50d1ea481909c07e63c3ead9316 completed April 16, 2026, 10:08 a.m.
NER Named-entity recognition batch_69e7252a48788190bfdfe811fc6cfc06 completed April 21, 2026, 7:20 a.m.
Created at: April 16, 2026, 2:58 p.m.